Join our 15,000+ followers on X: @iuemag_com
Wegovy, a weight-loss medication developed by Novo Nordisk, has gained significant attention for its effectiveness in helping individuals manage obesity. Lawsuits have surfaced recently, though, because of the drug's significant adverse effects, which include claims of stomach paralysis. Those who were victims of stomach paralysis caused by Wegovy are seeking justice through lawsuits against the manufacturer, alleging negligence in adequately warning users about the potential risks involved. This post aims to explore...